Here are five medical breakthroughs that gave us hope in 2025. In February, a baby with a rare, often fatal genetic disorder ...
A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...
Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...
VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.
CRISPR Therapeutics (NASDAQ: CRSP) soared a few years ago, climbing more than 200% from the start of 2020 through early 2021, ...
The popular nursery rhyme This Little Piggy is an early childhood memory for many of us. It’s a poem that involves five little piggies, each corresponding to one of our fingers or toes. Kids love it, ...
Morning Overview on MSN
CRISPR boosts a little-known fruit into a big farming win
Goldenberries have long been a niche curiosity, tucked into specialty produce aisles and health food shops while tomatoes and ...
Transposon sequencing analyses reveal that among genomically diverse clinical Mycobacterium intracellulare strains and the type strain, 131 genes were comprehensively identified as universal essential ...
It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...
O 15, 2025, Barclays analyst Luke Sergott raised the price target for TXG from $17 to $22 while maintaining an Overweight ...
Against this backdrop, a research team led by Dr. Guozhang Kang and Dr. Gezi Li from Henan Agricultural University, China, ...
CRISPR Therapeutics shares early autoimmune and lymphoma data for zugo-cel, showing strong responses, manageable safety, and expanded oncology plans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback